{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:54:03Z","timestamp":1790276043194,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck & Company"},{"name":"Rebiotix"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.idc.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T08:30:45Z","timestamp":1553934645000},"page":"485-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient"],"prefix":"10.1016","volume":"33","author":[{"given":"Anupam","family":"Pande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Dubberke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12185-010-0569-x","article-title":"Cytomegalovirus infection\/disease after hematopoietic stem cell transplantation","volume":"91","author":"Mori","year":"2010","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2141.2004.05056.x","article-title":"Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form","volume":"126","author":"Khaiboullina","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.idc.2019.02.008_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1537-2995.1998.38398222871.x","article-title":"Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time","volume":"38","author":"Larsson","year":"1998","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.idc.2019.02.008_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T\u00a0cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"s3","key":"10.1016\/j.idc.2019.02.008_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajt.12005","article-title":"Immune regulation of human herpesviruses and its implications for human transplantation","volume":"13","author":"Smith","year":"2013","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.idc.2019.02.008_bib6","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e0","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00430-015-0403-4","article-title":"Cytomegalovirus immune evasion of myeloid lineage cells","volume":"204","author":"Brinkmann","year":"2015","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/088282403322396064","article-title":"A\u00a0survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways","volume":"16","author":"Basta","year":"2003","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.008_bib10","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","article-title":"Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation","volume":"94","author":"Holmberg","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hon.2453","article-title":"Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant","volume":"36","author":"Marchesi","year":"2018","journal-title":"Hematol Oncol"},{"issue":"7","key":"10.1016\/j.idc.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016","volume":"14","author":"Baden","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.idc.2019.02.008_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOH.0000000000000085","article-title":"The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation","volume":"21","author":"Ljungman","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.idc.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","article-title":"The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy","volume":"103","author":"Boeckh","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.idc.2019.02.008_bib15","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A\u00a0comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib16","first-page":"78","article-title":"Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation","volume":"91","author":"Ljungman","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tid.12398","article-title":"Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV-seropositive patients after allogeneic hematopoietic cell transplantation","volume":"17","author":"Cohen","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation","volume":"7","author":"Styczynski","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"12","key":"10.1016\/j.idc.2019.02.008_bib19","first-page":"6551","article-title":"Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification","volume":"37","author":"Dziedzic","year":"2017","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.09.004","article-title":"Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review","volume":"342","author":"Ariza-Heredia","year":"2014","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12365","article-title":"Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis","volume":"17","author":"Crocchiolo","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2019.02.008_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2007.06.006","article-title":"Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources","volume":"13","author":"Walker","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/0885066613476454","article-title":"Cytomegalovirus pneumonia in hematopoietic stem cell recipients","volume":"29","author":"Travi","year":"2014","journal-title":"J\u00a0Intensive Care Med"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1705699","article-title":"Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies","volume":"40","author":"\u00d6zdemir","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1701827","article-title":"Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance","volume":"24","author":"Bilgrami","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1016\/j.idc.2019.02.008_bib27","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"El Chaer","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12185-008-0051-1","article-title":"Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"87","author":"Asano-Mori","year":"2008","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.200309-1322SO","article-title":"Pulmonary complications of solid organ and hematopoietic stem cell transplantation","volume":"170","author":"Kotloff","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.idc.2019.02.008_bib30","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbmt.2012.05.015","article-title":"Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation","volume":"18","author":"Green","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/318447","article-title":"Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation","volume":"32","author":"Crippa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2019.02.008_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/bbmt.2001.v7.pm11787530","article-title":"Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients","volume":"679","author":"van Burik","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/civ215","article-title":"Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices","volume":"61","author":"Erard","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.008_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","volume":"13","author":"van Burik","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.idc.2019.02.008_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies","volume":"9","author":"Boeckh","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/338624","article-title":"High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection","volume":"185","author":"Nichols","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European Group for Blood and Marrow Transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.V97.4.867","article-title":"Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes","volume":"97","author":"Nichols","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib39","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/JCM.42.3.1142-1148.2004","article-title":"Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR","volume":"42","author":"Boeckh","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2019.02.008_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biologicals.2016.04.005","article-title":"A\u00a0collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology","volume":"44","author":"Fryer","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.idc.2019.02.008_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcv.2018.04.013","article-title":"Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results","volume":"104","author":"Naegele","year":"2018","journal-title":"J\u00a0Clin Virol"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001622-200107000-00004","article-title":"Pneumonia in febrile neutropenic patients: radiologic diagnosis","volume":"13","author":"Maschmeyer","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.idc.2019.02.008_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1259\/bjr\/70800575","article-title":"Cytomegalovirus pneumonia after bone marrow transplantation: high resolution CT findings","volume":"77","author":"Gasparetto","year":"2004","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12879-017-2492-8","article-title":"Outcomes and prognostic factors of non-HIV patients with Pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: a retrospective cohort study","volume":"17","author":"Yu","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1378\/chest.119.3.838","article-title":"Pulmonary cytomegalovirus infection in immunocompromised patients","volume":"119","author":"Tamm","year":"2001","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.idc.2019.02.008_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-112-12-913","article-title":"Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia","volume":"112","author":"Ruutu","year":"1990","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.idc.2019.02.008_bib47","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ejca.2005.07.011","article-title":"Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center","volume":"41","author":"Torres","year":"2005","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.idc.2019.02.008_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/apt.12468","article-title":"Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms","volume":"38","author":"Liu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1705671","article-title":"Active CMV disease does not always correlate with viral load detection","volume":"40","author":"Ruell","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.idc.2019.02.008_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/bmt.2010.35","article-title":"CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency","volume":"45","author":"Reddy","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.idc.2019.02.008_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1399-3062.2010.00503.x","article-title":"Cytomegalovirus ventriculoencephalitis in a reduced- intensity conditioning cord blood transplant recipient","volume":"12","author":"Ando","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2002-07-1982","article-title":"Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients","volume":"101","author":"Wolf","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.tp.0000239512.94181.e9","article-title":"Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Xhaard","year":"2007","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.idc.2019.02.008_bib54","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ophtha.2012.03.032","article-title":"Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation","volume":"119","author":"Jeon","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.idc.2019.02.008_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2018.03.006","article-title":"Maribavir, brincidofovir and letermovir: efficacy and safety of new antiviral drugs for treating cytomegalovirus infections","author":"Frange","year":"2018","journal-title":"Med Mal Infect"},{"issue":"11","key":"10.1016\/j.idc.2019.02.008_bib56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.idc.2019.02.008_bib57","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"\u00c5sberg","year":"2007","journal-title":"Am J Transplant"},{"issue":"388","key":"10.1016\/j.idc.2019.02.008_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2018.02.029","article-title":"Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: a case report and review of the literature","volume":"15","author":"Baghban","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"issue":"10","key":"10.1016\/j.idc.2019.02.008_bib59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-109-10-783","article-title":"Treatment of cytomegalovirus pneumonia with Ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants","volume":"109","author":"Reed","year":"1988","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.idc.2019.02.008_bib60","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-109-10-777","article-title":"Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of Ganciclovir and high-dose intravenous immune globulin","volume":"109","author":"Emanuel","year":"1988","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib61","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/clinids\/14.4.831","article-title":"Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group","volume":"14","author":"Ljungman","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.008_bib62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.bmt.1701113","volume":"21","author":"Ljungman","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.idc.2019.02.008_bib63","first-page":"557","article-title":"Rapid generation of CMV pp65-specific T\u00a0cells for immunotherapy","volume":"30","author":"Bao","year":"2007","journal-title":"J\u00a0Immunother"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib64","first-page":"293","article-title":"Lymphocytes for stem cell transplant patients with refractory CMV infections","volume":"35","author":"Bao","year":"2013","journal-title":"J\u00a0Immunother"},{"issue":"10","key":"10.1016\/j.idc.2019.02.008_bib65","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T\u00a0cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.idc.2019.02.008_bib66","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/21505594.2016.1221022","article-title":"CMV-specific immune reconstitution following allogeneic stem cell transplantation","volume":"7","author":"Blyth","year":"2016","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1399-3062.2007.00249.x","article-title":"Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation","volume":"10","author":"West","year":"2008","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.008_bib68","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"23","key":"10.1016\/j.idc.2019.02.008_bib69","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198801143180202","article-title":"Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation","volume":"318","author":"Meyers","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2019.02.008_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bmt.1700498","article-title":"Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection","volume":"19","author":"Prentice","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-118-3-199302010-00004","article-title":"Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: results of a placebo-controlled, double-blind trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2019.02.008_bib73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","article-title":"Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant","volume":"118","author":"Goodrich","year":"1993","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.idc.2019.02.008_bib74","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idc.2019.02.008_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-2729","article-title":"Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized controlled trial","volume":"162","author":"Boeckh","year":"2015","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.idc.2019.02.008_bib76","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155201930011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155201930011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:13Z","timestamp":1760195833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089155201930011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S089155201930011X"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2019.02.008","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}